• Clip
• Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> Tom encourages other patients to think about taking part in a trial if it is offered. You can always withdraw if there are problems, and you will have

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

• Medical research >> Clinical Trials >> Cancer drugs and radiotherapy - randomised trials >> Rose - Interview 17 >> It is important for staff not to try to influence you. If you say yes just because you like the researcher it could cause problems.

Rose took part in a trial for people with inoperable lung cancer, comparing radiotherapy alone with radiotherapy plus chemotherapy. She had just radiotherapy. The trial was stopped early because so few people agreed to take part.

• Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> Tom was invited to join a non-randomised Phase 2 trial of chemotherapy for inoperable lung cancer. He knew it might not help him, but might help other

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

• Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> He knew he could stop if the side effects became too bad. He felt the staff explained it well, but not everyone wants as much information as he did.

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

• Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> Joining a trial when you have a serious illness is very different to ‘healthy volunteer’ trials. People need more information and education about tria

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.

• Medical research >> Clinical Trials >> Cancer drugs and radiotherapy - randomised trials >> Rose - Interview 17 >> Rose volunteered to ‘give something back’. She knew both treatments were tried and tested, and was happy to be in the control group. But she would hav

Rose took part in a trial for people with inoperable lung cancer, comparing radiotherapy alone with radiotherapy plus chemotherapy. She had just radiotherapy. The trial was stopped early because so few people agreed to take part.

• Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Tom - Interview 14 >> It was a relief when the trial ended and he no longer had to cope with side effects and lots of blood tests, but he also felt quite worried and unsure

Tom took part in a phase 2 trial of a new chemotherapy drug for lung cancer in 1993. Without the trial, the only other option at the time would have been palliative radiotherapy.